Keywords: Bayer, Xarelto, Amgen, Xgeva, UK, NICE

NICE recommendations on Bayer's Xarelto and Amgen Xgeva's for UK NHS use

Article | 30 March 2012

Print This

Following the receipt of further evidence from Bayer HealthCare, a unit of German drugmaker Bayer (BAY: DE), of the clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in